Physiological Study of the Human CYP3A Activity (PiSA)

NCT03204578 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cytochrome P450 CYP3A Enzyme Deficiency

Interventions

DRUG: AB (Midazolam OD formulation/Dormicum)
DRUG: BA (Dormicum/Midazolam OD formulation)

Sponsor

University Hospital, Basel, Switzerland